Effects of Ecological Restoration and Climate Change on Herbaceous and Arboreal Phenology

por Yuan, Zixuan, Cheng, Yiben, Mi, Lina, Xie, Jin, Xi, Jiaju, Mao, Yiru, Xu, Siqi, Wang, Zhengze, Wang, Saiqi
Publicado 2023

Dawning precision treatment for gastric cancer: The latest biomarkers

por Sun, Keran, Lv, Huifang, Chen, BeiBei, Nie, Caiyun, Zhao, Jing, Wang, Saiqi, Wang, Jianzheng, Xu, Weifeng, Chen, Xiaobing
Publicado 2021

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma

por Xu, Weifeng, Nie, Caiyun, Lv, Huifang, Chen, BeiBei, Wang, Jianzheng, Wang, Saiqi, Zhao, Jing, He, Yunduan, Chen, Xiaobing
Publicado 2022

Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells

por Wang, Cong, Guo, Liubin, Wang, Saiqi, Wang, Junwei, Li, Yongmei, Dou, Yinhui, Wang, Ran, Shi, Hongge, Ke, Yu, Liu, Hongmin
Publicado 2017

Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer

por Lv, Huifang, Zhang, Junling, Sun, Keran, Nie, Caiyun, Chen, Beibei, Wang, Jianzheng, Xu, Weifeng, Wang, Saiqi, Liu, Yingjun, Chen, Xiaobing
Publicado 2021

Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer

por Lv, Huifang, Zhang, Junling, Sun, Keran, Nie, Caiyun, Chen, Beibei, Wang, Jianzheng, Xu, Weifeng, Wang, Saiqi, Liu, Yingjun, Chen, Xiaobing
Publicado 2021

Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above thera...

por Nie, Caiyun, Lv, Huifang, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Liu, Yingjun, Wang, Saiqi, Zhao, Jing, He, Yunduan, Chen, Xiaobing
Publicado 2022

High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study

por Nie, Caiyun, Lv, Huifang, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Wang, Saiqi, Liu, Yingjun, He, Yunduan, Zhao, Jing, Chen, Xiaobing
Publicado 2023

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer

por Chen, Beibei, Zhao, Huichen, Huang, Jinxi, Lv, Huifang, Xu, Weifeng, Nie, Caiyun, Wang, Jianzheng, Zhao, Jing, He, Yunduan, Wang, Saiqi, Chen, Xiaobing
Publicado 2022

The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells

por Wang, Cong, Jiang, Liping, Wang, Saiqi, Shi, Hongge, Wang, Junwei, Wang, Ran, Li, Yongmei, Dou, Yinhui, Liu, Ying, Hou, Guiqin, Ke, Yu, Liu, Hongmin
Publicado 2015

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study

por Nie, Caiyun, Xu, Weifeng, Lv, Huifang, Gao, Xiaohui, Li, Guofeng, Chen, Beibei, Wang, Jianzheng, Liu, Yingjun, Zhao, Jing, He, Yunduan, Wang, Saiqi, Chen, Xiaobing
Publicado 2022